Cargando…
Phospholipids and Alzheimer’s Disease: Alterations, Mechanisms and Potential Biomarkers
Brain is one of the richest organs in lipid content. Phospholipids (glycerophospholipids and sphingolipids) are important building blocks of cell membranes, which provide an optimal environment for protein interactions, trafficking and function. Because of that, alterations in their cellular levels...
Autores principales: | Kosicek, Marko, Hecimovic, Silva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565322/ https://www.ncbi.nlm.nih.gov/pubmed/23306153 http://dx.doi.org/10.3390/ijms14011310 |
Ejemplares similares
-
Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins
por: Cermak, Stjepko, et al.
Publicado: (2016) -
Cholesterol-Dependent Energy Transfer between Fluorescent Proteins—Insights into Protein Proximity of APP and BACE1 in Different Membranes in Niemann-Pick Type C Disease Cells
por: von Einem, Bjoern, et al.
Publicado: (2012) -
Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer’s Disease Mimic Accelerated Aging
por: Dorninger, Fabian, et al.
Publicado: (2018) -
Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2022) -
Potential Retinal Biomarkers in Alzheimer’s Disease
por: García-Bermúdez, Mariana Yolotzin, et al.
Publicado: (2023)